Article metrics

Download PDFPDF

1201 SGN-BB228 is a first-in-class CD228-targeted costimulatory antibody anticalin® bispecific delivering potent and conditional 4–1BB costimulation to tumor-specific T cells
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022220017
Dec 202298011
Jan 2023220014
Feb 2023182021
Mar 2023262021
Apr 2023172018
May 202314408
Jun 2023120015
Jul 2023124018
Aug 2023130012
Sep 2023100015
Oct 202378010
Nov 20239606
Dec 2023170017
Jan 20246007
Total21760210